A Phase I Study for Safety and Tolerability of AL002.
Clinical trial NCT03635047 · COMPLETED
Trial details
- NCT number
- NCT03635047
- Sponsor
- Alector Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2020-08-03
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.